Buscar
Cibus Inc
CBUSAñadir a la lista de seguimiento
1.710USD
-0.070-3.93%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
130.44MCap. mercado
PérdidaP/E TTM
Más Datos de Cibus Inc Compañía
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Información de Cibus Inc
Símbolo de cotizaciónCBUS
Nombre de la empresaCibus Inc
Fecha de salida a bolsaJul 20, 2017
Director ejecutivoBeetham (Peter Ronald)
Número de empleados157
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 20
Dirección6455 Nancy Ridge Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18584500008
Sitio Webhttps://www.cibus.com/
Símbolo de cotizaciónCBUS
Fecha de salida a bolsaJul 20, 2017
Director ejecutivoBeetham (Peter Ronald)
Ejecutivos de Cibus Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Dr. Keith A. Walker, Ph.D.
Dr. Keith A. Walker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.96M
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
894.31K
--
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
592.70K
+38.19%
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
139.88K
+27.17%
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
104.94K
+61.70%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
85.47K
-35.32%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cibus Inc?
Los cinco principales accionistas de Cibus Inc son: Mr. Rory B. Riggs
¿Cuántas instituciones poseen acciones de Cibus Inc (CBUS)?
A fecha de 2026Q1, 162 instituciones poseen acciones de Cibus Inc, con un valor de mercado combinado de aproximadamente 12.20M, lo que representa el 16.60% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2351528.00.